Clinical Trial Update: A Study of LY2875358 in Japanese Participants With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of LY2875358 in Japanese participants with advanced cancer has completed, including non-small cell lung cancer and lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Non-small Cell Lung Cancer

Drugs mentioned

• LY2875358

Snippet

Sponsor: Eli Lilly and Company | Conditions: Solid Tumors, Lymphoma | Phase 1 | Status: COMPLETED